Clinical Trial Update: The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression [Phase 2]

View source ↗

Summary

Phase 2 trial update on Microbial Ecosystem Therapeutic-2 for major depressive disorder and anxiety, focusing on safety, efficacy, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Microbial Ecosystem Therapeutic-2

Snippet

Sponsor: NuBiyota | Conditions: Major Depressive Disorder, Anxiety | Phase 2 | Status: UNKNOWN